Clinical Trials Logo

Clinical Trial Summary

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as neostigmine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04492319
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase N/A
Start date September 29, 2020
Completion date December 20, 2023

See also
  Status Clinical Trial Phase
Completed NCT04498351 - Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine Early Phase 1
Enrolling by invitation NCT06313775 - Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy N/A